In continuation to the scientific discussions on COVID-19 vaccines research, WHO R&D Blueprint organized a consultation to review emerging data related to the omicron variant. This consultation took place on Wednesday, 15 December 2021 from 14h30 to 17h30 (CET) Geneva time.
Invited experts will included:
During this consultation, global experts reviewed the available evidence, critically appraised the data, and summarized the interpretation of evidence and next steps.
Session 1: Interpreting immunological and animal studies
Session 2: Emerging Data
WHO TOOLS AND RESOURCES
RECORDINGS, PRESENTATIONS, AND MEETING REPORTS